115 related articles for article (PubMed ID: 37865350)
21. TRIM21 Restricts Coxsackievirus B3 Replication, Cardiac and Pancreatic Injury via Interacting With MAVS and Positively Regulating IRF3-Mediated Type-I Interferon Production.
Liu H; Li M; Song Y; Xu W
Front Immunol; 2018; 9():2479. PubMed ID: 30410495
[TBL] [Abstract][Full Text] [Related]
22. Altered exosomal miR-181d and miR-30a related to the pathogenesis of CVB3 induced myocarditis by targeting SOCS3.
Fan KL; Li MF; Cui F; Feng F; Kong L; Zhang FH; Hao H; Yin MX; Liu Y
Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):2208-2215. PubMed ID: 30915768
[TBL] [Abstract][Full Text] [Related]
23. A phosphorothioate antisense oligodeoxynucleotide specifically inhibits coxsackievirus B3 replication in cardiomyocytes and mouse hearts.
Yuan J; Cheung PK; Zhang H; Chau D; Yanagawa B; Cheung C; Luo H; Wang Y; Suarez A; McManus BM; Yang D
Lab Invest; 2004 Jun; 84(6):703-14. PubMed ID: 15094712
[TBL] [Abstract][Full Text] [Related]
24. Zinc finger antiviral protein inhibits coxsackievirus B3 virus replication and protects against viral myocarditis.
Li M; Yan K; Wei L; Yang J; Lu C; Xiong F; Zheng C; Xu W
Antiviral Res; 2015 Nov; 123():50-61. PubMed ID: 26343012
[TBL] [Abstract][Full Text] [Related]
25. Adiponectin promotes coxsackievirus B3 myocarditis by suppression of acute anti-viral immune responses.
Jenke A; Holzhauser L; Löbel M; Savvatis K; Wilk S; Weithäuser A; Pinkert S; Tschöpe C; Klingel K; Poller W; Scheibenbogen C; Schultheiss HP; Skurk C
Basic Res Cardiol; 2014 May; 109(3):408. PubMed ID: 24691762
[TBL] [Abstract][Full Text] [Related]
26. Lithium chloride confers protection against viral myocarditis via suppression of coxsackievirus B3 virus replication.
Zhao Y; Yan K; Wang Y; Cai J; Wei L; Li S; Xu W; Li M
Microb Pathog; 2020 Jul; 144():104169. PubMed ID: 32205210
[TBL] [Abstract][Full Text] [Related]
27. Involvement of NLRP3 inflammasome in CVB3-induced viral myocarditis.
Wang Y; Gao B; Xiong S
Am J Physiol Heart Circ Physiol; 2014 Nov; 307(10):H1438-47. PubMed ID: 25260607
[TBL] [Abstract][Full Text] [Related]
28.
Lee YG; Park JH; Jeon ES; Kim JH; Lim BK
J Microbiol Biotechnol; 2016 Nov; 26(11):2012-2018. PubMed ID: 27558433
[TBL] [Abstract][Full Text] [Related]
29. Involvement of Endoplasmic Reticulum Stress-Mediated C/EBP Homologous Protein Activation in Coxsackievirus B3-Induced Acute Viral Myocarditis.
Cai Z; Shen L; Ma H; Yang J; Yang D; Chen H; Wei J; Lu Q; Wang DW; Xiang M; Wang J
Circ Heart Fail; 2015 Jul; 8(4):809-18. PubMed ID: 25985795
[TBL] [Abstract][Full Text] [Related]
30. Coxsackievirus B3 induces viral myocarditis by upregulating toll-like receptor 4 expression.
Zhao Z; Cai TZ; Lu Y; Liu WJ; Cheng ML; Ji YQ
Biochemistry (Mosc); 2015 Apr; 80(4):455-62. PubMed ID: 25869363
[TBL] [Abstract][Full Text] [Related]
31. Long non-coding RNA MEG3 inhibits M2 macrophage polarization by activating TRAF6 via microRNA-223 down-regulation in viral myocarditis.
Xue YL; Zhang SX; Zheng CF; Li YF; Zhang LH; Su QY; Hao YF; Wang S; Li XW
J Cell Mol Med; 2020 Nov; 24(21):12341-12354. PubMed ID: 33047847
[TBL] [Abstract][Full Text] [Related]
32. Role of neutrophils in CVB3 infection and viral myocarditis.
Rivadeneyra L; Charó N; Kviatcovsky D; de la Barrera S; Gómez RM; Schattner M
J Mol Cell Cardiol; 2018 Dec; 125():149-161. PubMed ID: 30393107
[TBL] [Abstract][Full Text] [Related]
33. In Vitro Model Systems of Coxsackievirus B3-Induced Myocarditis: Comparison of Commonly Used Cell Lines and Characterization of CVB3-Infected iCell
Kraft L; Sauter M; Seebohm G; Klingel K
Viruses; 2021 Sep; 13(9):. PubMed ID: 34578416
[TBL] [Abstract][Full Text] [Related]
34. Blockade of interleukin-17A protects against coxsackievirus B3-induced myocarditis by increasing COX-2/PGE2 production in the heart.
Xie Y; Chen R; Zhang X; Yu Y; Yang Y; Zou Y; Ge J; Chen H; Garzino-Demo A
FEMS Immunol Med Microbiol; 2012 Apr; 64(3):343-51. PubMed ID: 22141571
[TBL] [Abstract][Full Text] [Related]
35. Macrophage CAPN4 regulates CVB3-induced cardiac inflammation and injury by promoting NLRP3 inflammasome activation and phenotypic transformation to the inflammatory subtype.
Wang Y; Li M; Chen J; Yu Y; Yu Y; Shi H; Liu X; Chen Z; Chen R; Ge J
Free Radic Biol Med; 2023 Nov; 208():430-444. PubMed ID: 37660839
[TBL] [Abstract][Full Text] [Related]
36. Early Treatment of Coxsackievirus B3-Infected Animals With Soluble Coxsackievirus-Adenovirus Receptor Inhibits Development of Chronic Coxsackievirus B3 Cardiomyopathy.
Pinkert S; Dieringer B; Klopfleisch R; Savvatis K; Van Linthout S; Pryshliak M; Tschöpe C; Klingel K; Kurreck J; Beling A; Fechner H
Circ Heart Fail; 2019 Nov; 12(11):e005250. PubMed ID: 31718319
[TBL] [Abstract][Full Text] [Related]
37. MicroRNAs regulate the pathogenesis of CVB3-induced viral myocarditis.
Zhang Q; Xiao Z; He F; Zou J; Wu S; Liu Z
Intervirology; 2013; 56(2):104-13. PubMed ID: 23183417
[TBL] [Abstract][Full Text] [Related]
38. Mesenchymal stem cells improve murine acute coxsackievirus B3-induced myocarditis.
Van Linthout S; Savvatis K; Miteva K; Peng J; Ringe J; Warstat K; Schmidt-Lucke C; Sittinger M; Schultheiss HP; Tschöpe C
Eur Heart J; 2011 Sep; 32(17):2168-78. PubMed ID: 21183501
[TBL] [Abstract][Full Text] [Related]
39. 5'-Terminal deletions occur in coxsackievirus B3 during replication in murine hearts and cardiac myocyte cultures and correlate with encapsidation of negative-strand viral RNA.
Kim KS; Tracy S; Tapprich W; Bailey J; Lee CK; Kim K; Barry WH; Chapman NM
J Virol; 2005 Jun; 79(11):7024-41. PubMed ID: 15890942
[TBL] [Abstract][Full Text] [Related]
40. Recombinant Mouse β-Defensin 3 Protects against Coxsackievirus B3-Induced Myocarditis in Mice.
Jiang Y; Zhu R; Luo L; Mu Q; Zhu Y; Luo H; Zou X; Shen X
Intervirology; 2015; 58(6):343-9. PubMed ID: 26829552
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
